Logo image of EXPO

EXPONENT INC (EXPO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EXPO - US30214U1025 - Common Stock

74.675 USD
+1.05 (+1.42%)
Last: 12/15/2025, 8:26:46 PM
74.675 USD
0 (0%)
After Hours: 12/15/2025, 8:26:46 PM
Fundamental Rating

6

Overall EXPO gets a fundamental rating of 6 out of 10. We evaluated EXPO against 87 industry peers in the Professional Services industry. Both the health and profitability get an excellent rating, making EXPO a very profitable company, without any liquidiy or solvency issues. EXPO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPO was profitable.
EXPO had a positive operating cash flow in the past year.
Each year in the past 5 years EXPO has been profitable.
EXPO had a positive operating cash flow in each of the past 5 years.
EXPO Yearly Net Income VS EBIT VS OCF VS FCFEXPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

EXPO has a better Return On Assets (13.77%) than 89.66% of its industry peers.
The Return On Equity of EXPO (26.02%) is better than 78.16% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.36%, EXPO is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXPO is significantly above the industry average of 11.98%.
The 3 year average ROIC (18.56%) for EXPO is well above the current ROIC(14.36%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROIC 14.36%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
EXPO Yearly ROA, ROE, ROICEXPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

EXPO has a Profit Margin of 18.35%. This is amongst the best in the industry. EXPO outperforms 86.21% of its industry peers.
In the last couple of years the Profit Margin of EXPO has remained more or less at the same level.
EXPO has a better Operating Margin (20.64%) than 87.36% of its industry peers.
EXPO's Operating Margin has been stable in the last couple of years.
EXPO's Gross Margin of 92.96% is amongst the best of the industry. EXPO outperforms 98.85% of its industry peers.
EXPO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
EXPO Yearly Profit, Operating, Gross MarginsEXPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXPO is creating value.
Compared to 1 year ago, EXPO has more shares outstanding
EXPO has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPO Yearly Shares OutstandingEXPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EXPO Yearly Total Debt VS Total AssetsEXPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

EXPO has an Altman-Z score of 9.12. This indicates that EXPO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.12, EXPO belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.12
ROIC/WACC1.63
WACC8.83%
EXPO Yearly LT Debt VS Equity VS FCFEXPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.69, EXPO belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
A Quick Ratio of 2.69 indicates that EXPO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.69, EXPO belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.69
EXPO Yearly Current Assets VS Current LiabilitesEXPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

EXPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.97%.
The Earnings Per Share has been growing slightly by 6.74% on average over the past years.
The Revenue has been growing slightly by 4.90% in the past year.
The Revenue has been growing slightly by 6.01% on average over the past years.
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%

3.2 Future

Based on estimates for the next years, EXPO will show a small growth in Earnings Per Share. The EPS will grow by 5.06% on average per year.
EXPO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.32% yearly.
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue Next Year4.08%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
EXPO Yearly Revenue VS EstimatesEXPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EXPO Yearly EPS VS EstimatesEXPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.43 indicates a quite expensive valuation of EXPO.
EXPO's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of EXPO to the average of the S&P500 Index (26.55), we can say EXPO is valued slightly more expensively.
With a Price/Forward Earnings ratio of 32.83, EXPO can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, EXPO is valued a bit more expensive than 62.07% of the companies in the same industry.
EXPO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.78.
Industry RankSector Rank
PE 36.43
Fwd PE 32.83
EXPO Price Earnings VS Forward Price EarningsEXPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than 63.22% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as EXPO.
Industry RankSector Rank
P/FCF 30.31
EV/EBITDA 27.5
EXPO Per share dataEXPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The excellent profitability rating of EXPO may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.4
EPS Next 2Y3.58%
EPS Next 3Y5.06%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.63%, EXPO has a reasonable but not impressive dividend return.
EXPO's Dividend Yield is rather good when compared to the industry average which is at 1.55. EXPO pays more dividend than 80.46% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, EXPO has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

The dividend of EXPO is nicely growing with an annual growth rate of 28.57%!
EXPO has paid a dividend for at least 10 years, which is a reliable track record.
EXPO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)28.57%
Div Incr Years11
Div Non Decr Years11
EXPO Yearly Dividends per shareEXPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

58.07% of the earnings are spent on dividend by EXPO. This is a bit on the high side, but may be sustainable.
EXPO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP58.07%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EXPO Yearly Income VS Free CF VS DividendEXPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EXPO Dividend Payout.EXPO Dividend Payout, showing the Payout Ratio.EXPO Dividend Payout.PayoutRetained Earnings

EXPONENT INC

NASDAQ:EXPO (12/15/2025, 8:26:46 PM)

After market: 74.675 0 (0%)

74.675

+1.05 (+1.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners97.69%
Inst Owner Change-3.48%
Ins Owners0.96%
Ins Owner Change0.12%
Market Cap3.73B
Revenue(TTM)571.36M
Net Income(TTM)104.84M
Analysts82.22
Price Target84.66 (13.37%)
Short Float %5.22%
Short Ratio6.62
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend1.07
Dividend Growth(5Y)28.57%
DP58.07%
Div Incr Years11
Div Non Decr Years11
Ex-Date12-05 2025-12-05 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.34%
Max EPS beat(2)6.42%
EPS beat(4)4
Avg EPS beat(4)6.95%
Min EPS beat(4)3.34%
Max EPS beat(4)11.81%
EPS beat(8)7
Avg EPS beat(8)7.03%
EPS beat(12)8
Avg EPS beat(12)4.77%
EPS beat(16)12
Avg EPS beat(16)5.48%
Revenue beat(2)1
Avg Revenue beat(2)0.83%
Min Revenue beat(2)-0.43%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)0.05%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.68%
PT rev (3m)-5.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.77%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.96%
Valuation
Industry RankSector Rank
PE 36.43
Fwd PE 32.83
P/S 6.52
P/FCF 30.31
P/OCF 28.18
P/B 9.25
P/tB 9.45
EV/EBITDA 27.5
EPS(TTM)2.05
EY2.75%
EPS(NY)2.27
Fwd EY3.05%
FCF(TTM)2.46
FCFY3.3%
OCF(TTM)2.65
OCFY3.55%
SpS11.45
BVpS8.07
TBVpS7.9
PEG (NY)N/A
PEG (5Y)5.4
Graham Number19.3
Profitability
Industry RankSector Rank
ROA 13.77%
ROE 26.02%
ROCE 19.43%
ROIC 14.36%
ROICexc 21.82%
ROICexgc 22.3%
OM 20.64%
PM (TTM) 18.35%
GM 92.96%
FCFM 21.51%
ROA(3y)15.66%
ROA(5y)15.2%
ROE(3y)28.66%
ROE(5y)26.61%
ROIC(3y)18.56%
ROIC(5y)16.83%
ROICexc(3y)30.54%
ROICexc(5y)30.82%
ROICexgc(3y)31.45%
ROICexgc(5y)31.86%
ROCE(3y)25.12%
ROCE(5y)22.78%
ROICexgc growth 3Y-10.75%
ROICexgc growth 5Y-4.18%
ROICexc growth 3Y-10.36%
ROICexc growth 5Y-3.84%
OM growth 3Y-2.87%
OM growth 5Y0.97%
PM growth 3Y-3.48%
PM growth 5Y-0.25%
GM growth 3Y-0.15%
GM growth 5Y-0.21%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.68%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 103.34%
Profit Quality 117.23%
Current Ratio 2.69
Quick Ratio 2.69
Altman-Z 9.12
F-Score6
WACC8.83%
ROIC/WACC1.63
Cap/Depr(3y)141.73%
Cap/Depr(5y)120.6%
Cap/Sales(3y)2.21%
Cap/Sales(5y)1.87%
Profit Quality(3y)105.59%
Profit Quality(5y)110.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y3.72%
EPS 5Y6.74%
EPS Q2Q%10%
EPS Next Y-1.05%
EPS Next 2Y3.58%
EPS Next 3Y5.06%
EPS Next 5YN/A
Revenue 1Y (TTM)4.9%
Revenue growth 3Y6.2%
Revenue growth 5Y6.01%
Sales Q2Q%9.58%
Revenue Next Year4.08%
Revenue Next 2Y5.99%
Revenue Next 3Y6.32%
Revenue Next 5YN/A
EBIT growth 1Y6.51%
EBIT growth 3Y3.15%
EBIT growth 5Y7.03%
EBIT Next Year31.07%
EBIT Next 3Y16.45%
EBIT Next 5YN/A
FCF growth 1Y55.07%
FCF growth 3Y5.33%
FCF growth 5Y10.11%
OCF growth 1Y36.83%
OCF growth 3Y5.08%
OCF growth 5Y5.99%

EXPONENT INC / EXPO FAQ

What is the fundamental rating for EXPO stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPO.


What is the valuation status for EXPO stock?

ChartMill assigns a valuation rating of 2 / 10 to EXPONENT INC (EXPO). This can be considered as Overvalued.


Can you provide the profitability details for EXPONENT INC?

EXPONENT INC (EXPO) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for EXPO stock?

The Price/Earnings (PE) ratio for EXPONENT INC (EXPO) is 36.43 and the Price/Book (PB) ratio is 9.25.


Can you provide the dividend sustainability for EXPO stock?

The dividend rating of EXPONENT INC (EXPO) is 6 / 10 and the dividend payout ratio is 58.07%.